NCT01609127 - Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer | Biotech Hunter

Enrollment

213

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

July 31, 2014

Conditions

Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer

Interventions

DRUG

Tesetaxel

Tesetaxel 27 mg/m2 orally once on Day 1 of each 21-day cycle

DRUG

Tesetaxel

Tesetaxel 15 mg/m2 orally once every 7 days for 3 consecutive weeks on Day 1, Day 8, and Day 15 of each 28-day cycle

DRUG

Capecitabine

Capecitabine 1250 mg/m2 orally twice daily (in the morning and evening after a meal; equivalent to a total daily dose of 2500 mg/m2) on Day 1 through Day 14 of each 21-day cycle

Trial Locations (1)

38120

RECRUITING

The West Clinic, Memphis